LGVN

NASDAQ · Biotechnology

Longeveron Inc-A

Penny Stocks Biotech Stocks Healthcare Stocks

$0.51

+0.00 (+0.39%)

As of Feb 8, 2:28 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 7 88%

Hold 1 13%

Sell 0 0%

Price Target

Analyst Price Target +5,297.7% upside

Low Target $21.92

Average Target $27.69

High Target $40.08

Current Price $0.51

Current
$0.51

Target
$27.69

$21.92 $27.69 avg $40.08

Scenario Analysis

Bear Case

$21.92

4,172.9%

Low target

Base Case

$27.69

+5,297.7%

Avg target

Bull Case

$40.08

+7,712.9%

High target

Risk/Reward

1.8x

Balanced

Price in Context

52-Week High

$34.66

-98.5% from high

52-Week Low

$12.32

+-95.8% from low

Target vs 52W High

$27.69

-20.1% vs high

Next Earnings Report

Mar 6, 2026 · Before Market Open

18d

until earnings

EPS Est: $-0.42

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	37	68%	$257.58	+15.3%
AMGN Amgen Inc	Hold	41	54%	$190.87	-50.3%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	77%	$438.34	-8.3%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.2%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-68.8%
INSM Insmed Inc	Strong Buy	27	93%	$143.40	-4.3%
BIIB Biogen Inc	Hold	42	48%	$91.45	-54.5%